Muscular Dystrophies Clinical Trials

13 recruitingLast updated: June 18, 2026

There are 13 actively recruiting muscular dystrophies clinical trials across 10 countries. Studies span Not Applicable, Phase 2, Phase 3. Top locations include Boston, Massachusetts, United States, Bosisio Parini, Lecco, Italy, Barcelona, Barcelona, Spain. Updated daily from ClinicalTrials.gov.


Muscular Dystrophies Trials at a Glance

13 actively recruiting trials for muscular dystrophies are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Boston, Bosisio Parini, and Barcelona. Lead sponsors running muscular dystrophies studies include IRCCS Eugenio Medea, Leigh R. Hochberg, MD, PhD., and Dyne Therapeutics.

Browse muscular dystrophies trials by phase

Treatments under study

About Muscular Dystrophies Clinical Trials

Looking for clinical trials for Muscular Dystrophies? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Muscular Dystrophies trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Muscular Dystrophies clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Phase 2

Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients

Duchenne Muscular DystrophyDMDNeuromuscular Diseases+2 more
Satellos Bioscience, Inc.51 enrolled21 locationsNCT07287189
Recruiting
Not Applicable

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia

AnarthriaAmyotrophic Lateral SclerosisSpinal Cord Injuries+5 more
Leigh R. Hochberg, MD, PhD.3 enrolled2 locationsNCT05724173
Recruiting
Phase 3

Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)

Muscular Dystrophy, DuchenneDMDNeuromuscular Diseases (NMD)+10 more
Dyne Therapeutics90 enrolled1 locationNCT07608432
Recruiting
Not Applicable

ECoG BMI for Motor and Speech Control

StrokeMultiple SclerosisALS+2 more
Karunesh Ganguly3 enrolled1 locationNCT03698149
Recruiting

Genetic and Physical Study of Childhood Nerve and Muscle Disorders

Muscular DystrophiesMuscle MyopathiesHereditary Spastic Paraplegias+2 more
National Institute of Neurological Disorders and Stroke (NINDS)9,300 enrolled1 locationNCT01568658
Recruiting
Not Applicable

Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)

Spinal Cord Injuries (SCI)Amyotrophic Lateral Sclerosis(ALS)Muscular Dystrophies+6 more
Johns Hopkins University5 enrolled1 locationNCT07521930
Recruiting

Muscle Health Measurements Using Electrical Impedance Myography

Muscular DystrophiesMyositisCongenital Myopathy+4 more
Beth Israel Deaconess Medical Center150 enrolled1 locationNCT07502989
Recruiting

Observational Study to Observe Variations of Gait Parameters in Patients With Neuromuscular Diseases

Muscular DystrophiesCharcot-Marie-Tooth diseaseSpinal Muscular Atrophy (SMA)+1 more
IRCCS Eugenio Medea120 enrolled2 locationsNCT06666816
Recruiting
Not Applicable

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)

AnarthriaAmyotrophic Lateral SclerosisSpinal Cord Injuries+5 more
Leigh R. Hochberg, MD, PhD.2 enrolled1 locationNCT06094205
Recruiting

Phenotype - Genotype Correlation in a Sample of Egyptian Patients With Congenital Myopathies and Congenital Muscular Dystrophies

PhenotypeGenotypeCorrection+4 more
Ain Shams University25 enrolled1 locationNCT07138963
Recruiting
Not Applicable

Fear of Falling in Muscular Dystrophy

RehabilitationMuscular DystrophiesFear of Falling+1 more
Universita di Verona100 enrolled1 locationNCT07129954
Recruiting

Spanish Natural History Study for LAMA2 Muscular Dystrophy

Cohort StudiesMuscular DystrophiesLAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)+2 more
Hospital Universitari Vall d'Hebron Research Institute100 enrolled1 locationNCT06924125
Recruiting
Not Applicable

Rehabilitation in Muscular Dystrophies From the Hospital Facility to the Home: Pilot Project [RIMUDI]

Facio-Scapulo-Humeral DystrophyMuscular DystrophiesLimb Girdle Muscular Dystrophy
IRCCS Eugenio Medea10 enrolled1 locationNCT06378203